Our study demonstrated that rutin can alleviate the level of SOD1, improve motor performance, protect motor neurons, and reduce neuroinflammation in SOD1-G93A mice, making it a potential therapeutic agent candidate for ALS treatment. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.